跳至主要内容
临床试验/NCT04085354
NCT04085354已完成3 期

Evaluation of the Clinical Efficacy and Safety of Dapoxetine, Combined Dapoxetine With Folic Acid and Combined Dapoxetine With Vitamin B12 in Treatment of Patients With Premature Ejaculation: A Randomized Placebo-controlled Clinical Trial

Sohag University1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2019年2月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
120
试验地点
1
主要终点
Arabic Index of Premature Ejaculation

研究概览

简要总结

This study will aim to assess of the clinical efficacy and safety of dapoxetine, combined dapoxetine with folic acid and combined dapoxetine with vitamin B12 in treatment of patients with premature ejaculation: A randomized placebo-controlled clinical trial.

详细描述

In a single-blind placebo-controlled clinical study, it will be carried out on 120 patients with PE.

All patients will be randomized equally divided into four groups (30 patients each).

Group 1 was given placebo in form oral multivitamin tablet 1 h before intercourse.

Group 2 was given on-demand 30 mg dapoxetine 1-2 h before intercourse. Group 3 was given on-demand 30 mg dapoxetine 1-2 h before intercourse and daily oral supplementation of 0.5 mg folic acid.

Group 4 was given on-demand 30 mg dapoxetine 1-2 h before intercourse and daily oral supplementation of 0.5 mg vitamin B12

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

盲法说明

The distribution of the patients among the four groups was based on randomized coded cards, so the patients were unaware of the type of the drugs used.

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Premature ejaculation

排除标准

  • Erectile dysfunction
  • Diabetes mellitus
  • chronic prostatitis
  • Advanced renal or hepatic diseases
  • Neurological diseases

研究组 & 干预措施

Placebo

Placebo Comparator

Group 1 was given placebo in form oral multivitamin tablet 1 h before intercourse.

干预措施: Multi-Vitamin Tablets (Drug)

Dapoxetine

Active Comparator

Group 2 was given on-demand 30 mg dapoxetine 1-2 h before intercourse.

干预措施: Dapoxetine (Drug)

Dapoxetine and folic acid.

Active Comparator

Group 3 was given on-demand 30 mg dapoxetine 1-2 h before intercourse and daily oral supplementation of 0.5 mg folic acid.

干预措施: Dapoxetine and folic acid. (Drug)

Dapoxetine and vitamin B12

Active Comparator

Group 4 was given on-demand 30 mg dapoxetine 1-2 h before intercourse and daily oral supplementation of 0.5 mg vitamin B12

干预措施: Dapoxetine and vitamin B12 (Drug)

结局指标

主要结局

Arabic Index of Premature Ejaculation

时间窗: 0-6 weeks after treatment

The AIPE questionnaire includes seven questions.Response to each question will be scored on a scale from 1 to 5.

Intravaginal ejaculatory latency times

时间窗: 0-6 weeks after treatment

By using stopwatches

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohammed Abu El-Hamd

Assistant Professor of Dermatology, Venereology and Andrology Department, Faculty of Medicine, Sohag University, Egypt.

Sohag University

研究点 (1)

Loading locations...

相似试验

Evaluation of the Clinical Efficacy and Safety of... | 临床试验